Phase 1 Start~month

Phase 1 Start: Prospective, Multi-Center, Open-Label, Non-Randomized, Multi-Arm Study to Evaluate the Safety, Effic

Indication
Ocular Hypertension; Glaucoma

Other upcoming events for SGP

Phase 3 ReadoutPhase 3 Topline: A Prospective, Multicenter, Randomized, Masked, Controlled Study to Evaluate the Safety and Efficacy
Phase 3 ReadoutPhase 3 Topline: A Prospective, Multicenter, Randomized, Masked, Controlled Study to Evaluate the Safety and Efficacy

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 1 Start: Prospective, Multi-Center, Open-Label, Non-Randomized, Multi-Arm Study to Evaluate the Safety, Effic — SGP Phase 1 Start | BioSniper